STEREOSELECTIVE BINDING OF DISOPYRAMIDE TO HUMAN-PLASMA PROTEIN

[1] RESOLUTION, ABSOLUTE-CONFIGURATION, AND ANTI-ARRHYTHMIC PROPERTIES OF THE ENANTIOMERS OF DISOPYRAMIDE, 4-(DIISOPROPYLAMINO)-2-(2-PYRIDYL)-2-PHENYLBUTYRAMIDE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (09) : 1044 - 1048

[2] COOK CS, 1982, DRUG METAB DISPOS, V10, P111

[3] EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J]. CLINICAL PHARMACOKINETICS, 1977, 2 (05) : 373 - 383

[4] THE STEREOSELECTIVE DISPOSITION OF DISOPYRAMIDE IN THE DOG [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1980, 2 (06) : 825 - 832

[5] THE EFFECT OF SATURABLE BINDING TO PLASMA-PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDE [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01): : 1 - 14

[6] INFLUENCE OF CONCENTRATION-DEPENDENT PROTEIN-BINDING ON SERUM CONCENTRATIONS AND URINARY-EXCRETION OF DISOPYRAMIDE AND ITS METABOLITE FOLLOWING ORAL-ADMINISTRATION [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (02) : 103 - 112

[7] PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) : 1684 - 1690

[8] PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03): : 199 - 230

[9] HUANG JD, 1983, RES COMMUN CHEM PATH, V41, P227

[10] KARIM A, 1977, ARCH INT PHARMACOD T, V228, P222

[1] RESOLUTION, ABSOLUTE-CONFIGURATION, AND ANTI-ARRHYTHMIC PROPERTIES OF THE ENANTIOMERS OF DISOPYRAMIDE, 4-(DIISOPROPYLAMINO)-2-(2-PYRIDYL)-2-PHENYLBUTYRAMIDE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (09) : 1044 - 1048

[2] COOK CS, 1982, DRUG METAB DISPOS, V10, P111

[3] EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J]. CLINICAL PHARMACOKINETICS, 1977, 2 (05) : 373 - 383

[4] THE STEREOSELECTIVE DISPOSITION OF DISOPYRAMIDE IN THE DOG [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1980, 2 (06) : 825 - 832

[5] THE EFFECT OF SATURABLE BINDING TO PLASMA-PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDE [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01): : 1 - 14

[6] INFLUENCE OF CONCENTRATION-DEPENDENT PROTEIN-BINDING ON SERUM CONCENTRATIONS AND URINARY-EXCRETION OF DISOPYRAMIDE AND ITS METABOLITE FOLLOWING ORAL-ADMINISTRATION [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (02) : 103 - 112

[7] PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) : 1684 - 1690

[8] PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03): : 199 - 230

[9] HUANG JD, 1983, RES COMMUN CHEM PATH, V41, P227

[10] KARIM A, 1977, ARCH INT PHARMACOD T, V228, P222